Bausch Health Companies INC Form 4 insider transactions

Aimee J. Lenar, President, US Pharma of Bausch Health Companies Inc., reported a transaction in 5,260 shares of common stock on July 17, 2026.

Aimee J. Lenar, President, US Pharma of Bausch Health Companies Inc., reported a transaction in 23,395 shares of common stock on July 15, 2026.

Steven Hyosig Lee, SVP, Controller & CAO of Bausch Health Companies Inc., reported a transaction in 3,125 shares of common stock on July 14, 2026.

Amy B. Wechsler, a Director at Bausch Health Companies Inc., acquired 1,394 common shares through Restricted Share Units.

John Paulson, a director at Bausch Health Companies Inc., acquired 12,677 common shares through restricted stock units.

Amy B. Wechsler, a Director at Bausch Health Companies Inc., was granted restricted stock units valued at $250,000.

Bausch Health Companies Inc. director Eiry Roberts received an award of restricted share units valued at $250,000, which will vest prior to the next annual shareholder meeting.

Robert N. Power, a Director at Bausch Health Companies Inc. (BHC), acquired 45,871 common shares through an RSU award.

John Paulson, a Director at Bausch Health Companies Inc., acquired restricted stock units valued at $250,000.

Director Sandra Leung of Bausch Health Companies Inc. acquired restricted stock units valued at $250,000, which will vest prior to the next annual meeting.

Frank D. Lee, a Director at Bausch Health Companies Inc., acquired 45,871 common shares through an RSU award.

Sarah B. Kavanagh, a Director at Bausch Health Companies Inc., was granted restricted share units valued at $250,000.

Michael Goettler, a Director at Bausch Health Companies Inc., was granted 45,871 restricted share units valued at $250,000.

Bausch Health Companies Inc. director Christian A. Garcia was granted restricted stock units valued at $250,000.

Director Frank D. Lee sold 24,456 shares of Bausch Health Companies Inc. to cover tax obligations related to vested equity awards.

Bausch Health Companies Inc. Director Sandra Leung acquired 5,946 restricted share units, reflecting compensation for board service.

John Paulson, a Director at Bausch Health Companies Inc., acquired 11,574 common shares through restricted stock units.

Amy B. Wechsler, a Director at Bausch Health Companies Inc., acquired 1,273 common shares through restricted stock units.

Bausch Health Companies Inc. EVP and CFO Jean-Jacques Charhon disposed of 49,060 common shares to cover tax obligations from vested Restricted Share Units.

Bausch Health Companies Inc.'s EVP and General Counsel, Seana Carson, reported multiple dispositions of common shares and performance share units, including sales under a 10b5-1 plan and tax withholdings.

Bausch Health CEO Thomas Appio reported the disposal of common shares for tax obligations and the cash settlement of over 1.1 million performance share units.

Bausch Health Companies Inc. awarded 45,868 restricted share units to Steven Hyosig Lee, SVP, Controller & CAO, as part of his compensation.

Bausch Health Companies Inc. EVP Aimee J. Lenar reported the acquisition of restricted share units and a subsequent sale of shares to cover tax obligations.

Bausch Health's EVP and General Counsel, Seana Carson, reported an award of restricted share units and subsequent sales of common shares, including tax-related withholdings and an open market sale under a 10b5-1 plan.

Bausch Health Companies Inc.'s EVP and CFO, Jean-Jacques Charhon, was granted 276,055 restricted share units and subsequently disposed of 35,977 shares to cover tax obligations.

Bausch Health Companies Inc. CEO Thomas Appio received an award of 815,425 restricted share units, with a portion subsequently withheld for tax obligations.

Bausch Health CEO Thomas Appio earned over 1.1 million common shares after meeting performance targets for the 2023-2025 period.

Bausch Health Companies Inc.'s EVP and General Counsel, Seana Carson, earned 137,922 performance-based restricted share units following the achievement of financial metrics.

Bausch Health Companies Inc. Director John Paulson reported the acquisition of 8,992 common shares through Restricted Share Units as compensation for his board service.

Bausch Health Companies Inc. director Sandra Leung acquired 4,586 common shares as restricted share units in lieu of cash compensation for her board service.